Literature DB >> 820642

Adjuvant activity of mycobacterial fractions: adjuvant activity of synthetic N-acetylmuramyl-dipeptide and the related compounds.

I Azuma, K Sugimura, T Taniyama, M Yamawaki, Y Yamamura.   

Abstract

Immunological activity of synthetic cell wall peptidoglycan subunits was examined in guinea pigs and mice. It was concluded that the minimal adjuvant-active subunit of cell wall peptidoglycan for the induction of delayed-type hypersensitivity to monoazobenzenearsonate-N-acetyl-L-tyrosine and for circulating-antibody formation to bacterial alpha-amylase and the thymus-independent antigen DNP-Ficoll was N-acetylmuramyldipeptide, MurNAc-L-Ala-D-isoGln. N-acetylmuramyldipeptide and 6-O-stearoyl-N-acetylmuramyldipeptide showed no adjuvant activity in the generation of cell-mediated cytotoxic effector cells in the spleens of C57Bl/6J mice after in vivo immunization with the allogeneic antigen mastocytoma P815-X2 cells, but N-acetylmuramyldipeptide showed adjuvant activity after in vitro sensitization of C57Bl/6J mouse spleen cells to the alloantigen mitomycin C-treated DBA/2 mouse spleen cells. It was also shown that 6-O-stearoylation of N-acetylmuramylpeptide could not potentiate the adjuvant activity of N-acetylmuramyldipeptide. Mitogenic and antitumor activities were not observed in either N-acetylmuramyldipeptide or 6-O-stearoyl-N-acetylmuramyldipeptide in mouse systems.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 820642      PMCID: PMC420838          DOI: 10.1128/iai.14.1.18-27.1976

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  27 in total

1.  Adjuvant activity of synthetic cell-wall peptidoglycan subunits on monoazobenzenearsonate-N-acetyl-L-tyrosine and bacterial alpha-amylase in guinea pigs.

Authors:  I Azuma; K Sugimura; Y Yamamura; S Kusumoto; Y Tarumi
Journal:  Jpn J Microbiol       Date:  1976-02

2.  DNP-Lys-ficoll: a T-independent antigen which elicits both IgM and IgG anti-DNP antibody-secreting cells.

Authors:  R Sharon; P R McMaster; A M Kask; J D Owens; W E Paul
Journal:  J Immunol       Date:  1975-05       Impact factor: 5.422

3.  Blast transformation of rabbit B-derived lymphocytes by a mitogen extracted from Nocardia.

Authors:  C Bona; L Chedid; C Damais; R Ciorbaru; P N Shek; S Dubiski; B Cinader
Journal:  J Immunol       Date:  1975-01       Impact factor: 5.422

4.  Mitogenic effect of bacterial peptidoglycans possessing adjuvant activity.

Authors:  C Damais; C Bona; L Chedid; J Fleck; C Nauciel; J P Martin
Journal:  J Immunol       Date:  1975-07       Impact factor: 5.422

5.  Comparison between macrophage activation and enhancement of nonspecific resistance to tumors by mycobacterial immunoadjuvants.

Authors:  D Juy; L Chedid
Journal:  Proc Natl Acad Sci U S A       Date:  1975-10       Impact factor: 11.205

6.  Adjuvant activity of mycobacterial fractions. III. Adjuvant effect of cell wall of Mycobacterium bovis BCG on cell-mediated cytotoxicity in mice.

Authors:  T Taniyama; I Azuma; Y Yamamura
Journal:  Jpn J Microbiol       Date:  1975-08

7.  Chemical and immunological studies on the cell walls of Propionibacterium acnes strain C7 and Corynebacterium parvum ATCC 11829.

Authors:  I Azuma; K Sugimura; T Taniyama; A Aladin; Y Yamamura
Journal:  Jpn J Microbiol       Date:  1975-08

8.  Adjuvant activity of mycobacterial fractions. I. Purification and in vivo adjuvant activity of cell wall skeletons of Mycobacterium bovis BCG, Nocardia asteroides 131 and Corynebacterium diphtheriae PW8.

Authors:  I Azuma; F Kanetsuna; T Taniyama; Y Yamamura; M Hori
Journal:  Biken J       Date:  1975-03

9.  Listeria cell wall fraction: a B cell mitogen.

Authors:  J J Cohen; G E Rodriguez; P D Kind; P A Campbell
Journal:  J Immunol       Date:  1975-03       Impact factor: 5.422

10.  Immunoadjuvant activities of synthetic N-acetyl-muramyl-peptides or -amino acids.

Authors:  S Kotani; Y Watanabe; F Kinoshita; T Shimono; I Morisaki
Journal:  Biken J       Date:  1975-06
View more
  30 in total

1.  Synergistic effects of romurtide and cefmenoxime against experimental Klebsiella pneumonia in mice.

Authors:  O Tatara; C Nakahama; Y Niki
Journal:  Antimicrob Agents Chemother       Date:  1992-01       Impact factor: 5.191

2.  Relationship between lymphoid cell population and levels of cholesterol or phospholipids.

Authors:  S Kigoshi
Journal:  Experientia       Date:  1978-09-15

3.  Adjuvant activity of purified peptidoglycan of Listeria monocytogenes in mice and guinea pigs.

Authors:  I Saiki; K Kamisango; Y Tanio; H Okumura; Y Yamamura; I Azuma
Journal:  Infect Immun       Date:  1982-10       Impact factor: 3.441

4.  Comparison of antitumor activity of Lactobacillus casei with other bacterial immunopotentiators.

Authors:  N Yasutake; M Ohwaki; T Yokokura; M Mutai
Journal:  Med Microbiol Immunol       Date:  1984       Impact factor: 3.402

5.  Adjuvant activity of 6-O-mycoloyl derivatives of N-acetylmuramyl-L-seryl-D-isoglutamine and related compounds in mice and guinea pigs.

Authors:  M Uemiya; K Sugimura; T Kusama; I Saiki; M Yamawaki; I Azuma; Y Yamamura
Journal:  Infect Immun       Date:  1979-04       Impact factor: 3.441

6.  Adjuvant activities in production of reaginic antibody by bacterial cell wall peptidoglycan or synthetic N-acetylmuramyl dipeptides in mice.

Authors:  H Ohkuni; Y Norose; M Ohta; M Hayama; Y Kimura; M Tsujimoto; S Kotani; T Shiba; S Kusumoto; K Yokogawa; S Kawata
Journal:  Infect Immun       Date:  1979-05       Impact factor: 3.441

7.  Stimulation of the reticuloendothelial system of mice by muramyl dipeptide.

Authors:  A Tanaka; S Nagao; R Nagao; S Kotani; T Shiba; S Kusumoto
Journal:  Infect Immun       Date:  1979-05       Impact factor: 3.441

8.  Polymorphonuclear leukocyte activation by a synthetic muramyl dipeptide analog.

Authors:  Y Osada; T Otani; M Sato; T Une; K Matsumoto; H Ogawa
Journal:  Infect Immun       Date:  1982-12       Impact factor: 3.441

9.  Adjuvant activities of quinonyl-N-acetyl muramyl dipeptides in mice and guinea pigs.

Authors:  I Saiki; Y Tanio; M Yamawaki; M Uemiya; S Kobayashi; T Fukuda; H Yukimasa; Y Yamamura; I Azuma
Journal:  Infect Immun       Date:  1981-01       Impact factor: 3.441

10.  Persistent enhancement of cell-mediated and antibody immune responses after administration of muramyl dipeptide derivatives with antigen in metabolizable oil.

Authors:  C Carelli; F Audibert; L Chedid
Journal:  Infect Immun       Date:  1981-07       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.